Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for addressing Attention-Deficit/Hyperactivity Dysfunction in youngsters and people. This functions as a prodrug, meaning it’s dormant until metabolized by the body, dispensing dextroamphetamine gradually over an extend… Read More